HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 22,550
+1,800 (8.67%)
At close: Oct 1, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 295.92 billion as of October 1, 2026. Its market cap has increased by 45.69% in one year.
Market Cap
295.92B
Enterprise Value
318.06B
Revenue
124.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,550.00
ChartMarket Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 295.92B, an increase of 503.86%. That is a compound annual growth rate of 11.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 295.92B | -21.66% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 514.15B |
| ROKIT Healthcare | 475.78B |
| Curocell | 329.67B |
| Inventage Lab | 316.06B |
| IMBiologics | 256.23B |
| S.Biomedics | 255.13B |
| IntoCell | 249.97B |
| Genome & Company | 234.82B |